مصطلحات الفهرس: nuclear magnetic resonance imaging, spinal cord supratentorial glioblastoma/dt [Drug Therapy], spinal cord tumor/di [Diagnosis], spinal cord tumor/dt [Drug Therapy], urine retention, bevacizumab/dt [Drug Therapy], isocitrate dehydrogenase 1/ec [Endogenous Compound], IDH1 gene, spinal cord supratentorial glioblastoma/di [Diagnosis], middle aged, abnormal sensation, adult, article, brain biopsy, cancer chemotherapy, case report, cerebrospinal fluid examination, contrast enhancement, gait disorder, gene mutation, glioblastoma/di [Diagnosis], glioblastoma/dt [Drug Therapy], human, immunohistochemistry, male, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/39496
Journal of Clinical Neuroscience
Click here for full text options
LibKey Link

مصطلحات الفهرس: nuclear magnetic resonance imaging, spinal cord supratentorial glioblastoma/dt [Drug Therapy], spinal cord tumor/di [Diagnosis], spinal cord tumor/dt [Drug Therapy], urine retention, bevacizumab/dt [Drug Therapy], isocitrate dehydrogenase 1/ec [Endogenous Compound], IDH1 gene, spinal cord supratentorial glioblastoma/di [Diagnosis], middle aged, abnormal sensation, adult, article, brain biopsy, cancer chemotherapy, case report, cerebrospinal fluid examination, contrast enhancement, gait disorder, gene mutation, glioblastoma/di [Diagnosis], glioblastoma/dt [Drug Therapy], human, immunohistochemistry, male, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/39496
Journal of Clinical Neuroscience
Click here for full text options
LibKey Link

مصطلحات الفهرس: drug absorption, drug bioavailability, drug contraindication, drug efficacy, drug metabolism, drug safety, erythema annulare centrifugum/si [Side Effect], erythema multiforme/si [Side Effect], eye examination, gastrointestinal symptom/si [Side Effect], giant cell granuloma/dt [Drug Therapy], glioblastoma/dt [Drug Therapy], glucose 6 phosphate dehydrogenase deficiency, granuloma annulare/dt [Drug Therapy], heart protection, heartburn/si [Side Effect], human, hyperpigmentation/si [Side Effect], hypertransaminasemia/si [Side Effect], hypoglycemia/si [Side Effect], immunomodulation, irritability, leukopenia/si [Side Effect], lichen (disease)/dt [Drug Therapy], lichen planus/dt [Drug Therapy], lichen sclerosus et atrophicus/dt [Drug Therapy], liver toxicity/si [Side Effect], lung cancer/dt [Drug Therapy], lupus vulgaris/dt [Drug Therapy], measles like rash/si [Side Effect], melanoma/dt [Drug Therapy], mood change, morphea/dt [Drug Therapy], mucinosis/dt [Drug Therapy], multiple myeloma/dt [Drug Therapy], nausea/si [Side Effect], necrobiosis lipoidica/dt [Drug Therapy], nightmare/si [Side Effect], nonhuman, outcome assessment, pancreas cancer/dt [Drug Therapy], panniculitis/dt [Drug Therapy], patient monitoring, pharmacodynamics, photodermatosis/dt [Drug Therapy], porphyria cutanea tarda/dt [Drug Therapy], practice guideline, pregnancy, prescription, pruritus/si [Side Effect], psoriasis/si [Side Effect], rash/si [Side Effect], retina maculopathy/si [Side Effect], retinopathy/si [Side Effect], review, risk benefit analysis, risk reduction, sarcoma/dt [Drug Therapy], side effect/si [Side Effect], skin contusion/si [Side Effect], skin sarcoidosis/dt [Drug Therapy], smoking, solid malignant neoplasm/dt [Drug Therapy], Stevens Johnson syndrome/si [Side Effect], systemic lupus erythematosus/dt [Drug Therapy], systemic sclerosis/dt [Drug Therapy], toxic epidermal necrolysis/si [Side Effect], treatment response, urticaria/si [Side Effect], vasculitis/dt [Drug Therapy], visual impairment/si [Side Effect], vomiting/si [Side Effect], cyclosporine/it [Drug Interaction], digoxin/it [Drug Interaction], glucose 6 phosphate dehydrogenase/ec [Endogenous Compound], hydroxychloroquine/ae [Adverse Drug Reaction], hydroxychloroquine/it [Drug Interaction], hydroxychloroquine/dt [Drug Therapy], hydroxychloroquine/pk [Pharmacokinetics], hydroxychloroquine/pd [Pharmacology], methotrexate/it [Drug Interaction], follicular mucinosis/dt [Drug Therapy], lichen planopilaris/dt [Drug Therapy], reticular erythematous mucinosis/dt [Drug Therapy], urticarial vasculitis/dt [Drug Therapy], laboratory test, abdominal distension/si [Side Effect], acute generalized exanthematous pustulosis/si [Side Effect], agranulocytosis/si [Side Effect], alopecia/si [Side Effect], alopecia areata/dt [Drug Therapy], anorexia/si [Side Effect], antineoplastic activity, antiphospholipid syndrome/dt [Drug Therapy], antithrombotic activity, aplastic anemia/si [Side Effect], blood toxicity/si [Side Effect], chronic urticaria/dt [Drug Therapy], dermatology, dermatomyositis/dt [Drug Therapy], diarrhea/si [Side Effect], DRESS syndrome/si [Side Effect], Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/35375
Australasian Journal of Dermatology
Click here for full text options
LibKey Link

مصطلحات الفهرس: protein cleavage, protein cross linking, protein degradation, protein expression, protein phosphorylation, signal transduction, upregulation, antineoplastic monoclonal antibody/cb [Drug Combination], antineoplastic monoclonal antibody/dt [Drug Therapy], antineoplastic monoclonal antibody/ip [Intraperitoneal Drug Administration], antineoplastic monoclonal antibody/pd [Pharmacology], cetuximab/cb [Drug Combination], cetuximab/dt [Drug Therapy], cetuximab/pd [Pharmacology], epidermal growth factor receptor/ec [Endogenous Compound], epidermal growth factor receptor antibody/ec [Endogenous Compound], immunoglobulin Fc fragment/ec [Endogenous Compound], matuzumab/dt [Drug Therapy], matuzumab/pd [Pharmacology], mitogen activated protein kinase 3/ec [Endogenous Compound], necitumumab/dt [Drug Therapy], necitumumab/pd [Pharmacology], nimotuzumab/dt [Drug Therapy], nimotuzumab/pd [Pharmacology], panitumumab/dt [Drug Therapy], panitumumab/pd [Pharmacology], protein S6/ec [Endogenous Compound], unclassified drug, ch 806/cb [Drug Combination], ch 806/dt [Drug Therapy], ch 806/ip [Intraperitoneal Drug Administration], ch 806/pd [Pharmacology], amino terminal sequence, animal experiment, animal model, antineoplastic activity, antiproliferative activity, article, cancer survival, carboxy terminal sequence, carcinogenesis, cell proliferation, controlled study, disulfide bond, drug efficacy, drug targeting, enzyme phosphorylation, glioblastoma/dt [Drug Therapy], glioblastoma/et [Etiology], glioblastoma cell line, human, human cell, in vitro study, in vivo study, internalization, mouse, nonhuman, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/35355
Neuro-Oncology
Click here for full text options
LibKey Link

مصطلحات الفهرس: drug absorption, drug bioavailability, drug contraindication, drug efficacy, drug metabolism, drug safety, erythema annulare centrifugum/si [Side Effect], erythema multiforme/si [Side Effect], eye examination, gastrointestinal symptom/si [Side Effect], giant cell granuloma/dt [Drug Therapy], glioblastoma/dt [Drug Therapy], glucose 6 phosphate dehydrogenase deficiency, granuloma annulare/dt [Drug Therapy], heart protection, heartburn/si [Side Effect], human, hyperpigmentation/si [Side Effect], hypertransaminasemia/si [Side Effect], hypoglycemia/si [Side Effect], immunomodulation, irritability, leukopenia/si [Side Effect], lichen (disease)/dt [Drug Therapy], lichen planus/dt [Drug Therapy], lichen sclerosus et atrophicus/dt [Drug Therapy], liver toxicity/si [Side Effect], lung cancer/dt [Drug Therapy], lupus vulgaris/dt [Drug Therapy], measles like rash/si [Side Effect], melanoma/dt [Drug Therapy], mood change, morphea/dt [Drug Therapy], mucinosis/dt [Drug Therapy], multiple myeloma/dt [Drug Therapy], nausea/si [Side Effect], necrobiosis lipoidica/dt [Drug Therapy], nightmare/si [Side Effect], nonhuman, outcome assessment, pancreas cancer/dt [Drug Therapy], panniculitis/dt [Drug Therapy], patient monitoring, pharmacodynamics, photodermatosis/dt [Drug Therapy], porphyria cutanea tarda/dt [Drug Therapy], practice guideline, pregnancy, prescription, pruritus/si [Side Effect], psoriasis/si [Side Effect], rash/si [Side Effect], retina maculopathy/si [Side Effect], retinopathy/si [Side Effect], review, risk benefit analysis, risk reduction, sarcoma/dt [Drug Therapy], side effect/si [Side Effect], skin contusion/si [Side Effect], skin sarcoidosis/dt [Drug Therapy], smoking, solid malignant neoplasm/dt [Drug Therapy], Stevens Johnson syndrome/si [Side Effect], systemic lupus erythematosus/dt [Drug Therapy], systemic sclerosis/dt [Drug Therapy], toxic epidermal necrolysis/si [Side Effect], treatment response, urticaria/si [Side Effect], vasculitis/dt [Drug Therapy], visual impairment/si [Side Effect], vomiting/si [Side Effect], cyclosporine/it [Drug Interaction], digoxin/it [Drug Interaction], glucose 6 phosphate dehydrogenase/ec [Endogenous Compound], hydroxychloroquine/ae [Adverse Drug Reaction], hydroxychloroquine/it [Drug Interaction], hydroxychloroquine/dt [Drug Therapy], hydroxychloroquine/pk [Pharmacokinetics], hydroxychloroquine/pd [Pharmacology], methotrexate/it [Drug Interaction], follicular mucinosis/dt [Drug Therapy], lichen planopilaris/dt [Drug Therapy], reticular erythematous mucinosis/dt [Drug Therapy], urticarial vasculitis/dt [Drug Therapy], laboratory test, abdominal distension/si [Side Effect], acute generalized exanthematous pustulosis/si [Side Effect], agranulocytosis/si [Side Effect], alopecia/si [Side Effect], alopecia areata/dt [Drug Therapy], anorexia/si [Side Effect], antineoplastic activity, antiphospholipid syndrome/dt [Drug Therapy], antithrombotic activity, aplastic anemia/si [Side Effect], blood toxicity/si [Side Effect], chronic urticaria/dt [Drug Therapy], dermatology, dermatomyositis/dt [Drug Therapy], diarrhea/si [Side Effect], DRESS syndrome/si [Side Effect], Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/35375
Australasian Journal of Dermatology
LibKey Link

مصطلحات الفهرس: protein cleavage, protein cross linking, protein degradation, protein expression, protein phosphorylation, signal transduction, upregulation, antineoplastic monoclonal antibody/cb [Drug Combination], antineoplastic monoclonal antibody/dt [Drug Therapy], antineoplastic monoclonal antibody/ip [Intraperitoneal Drug Administration], antineoplastic monoclonal antibody/pd [Pharmacology], cetuximab/cb [Drug Combination], cetuximab/dt [Drug Therapy], cetuximab/pd [Pharmacology], epidermal growth factor receptor/ec [Endogenous Compound], epidermal growth factor receptor antibody/ec [Endogenous Compound], immunoglobulin Fc fragment/ec [Endogenous Compound], matuzumab/dt [Drug Therapy], matuzumab/pd [Pharmacology], mitogen activated protein kinase 3/ec [Endogenous Compound], necitumumab/dt [Drug Therapy], necitumumab/pd [Pharmacology], nimotuzumab/dt [Drug Therapy], nimotuzumab/pd [Pharmacology], panitumumab/dt [Drug Therapy], panitumumab/pd [Pharmacology], protein S6/ec [Endogenous Compound], unclassified drug, ch 806/cb [Drug Combination], ch 806/dt [Drug Therapy], ch 806/ip [Intraperitoneal Drug Administration], ch 806/pd [Pharmacology], amino terminal sequence, animal experiment, animal model, antineoplastic activity, antiproliferative activity, article, cancer survival, carboxy terminal sequence, carcinogenesis, cell proliferation, controlled study, disulfide bond, drug efficacy, drug targeting, enzyme phosphorylation, glioblastoma/dt [Drug Therapy], glioblastoma/et [Etiology], glioblastoma cell line, human, human cell, in vitro study, in vivo study, internalization, mouse, nonhuman, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/35355
Neuro-Oncology
LibKey Link

مصطلحات الفهرس: protein cleavage, protein expression, protein function, protein interaction, protein localization, protein phosphorylation, survival rate, upregulation, dacomitinib/dt [Drug Therapy], epidermal growth factor receptor 4/ec [Endogenous Compound], messenger RNA/ec [Endogenous Compound], panitumumab, carcinogenicity, angiogenesis, animal cell, animal experiment, animal model, article, cancer prognosis, cancer survival, cell activation, cell count, cell growth, cell proliferation, concentration response, cross reaction, disease marker, drug efficacy, drug response, drug tolerability, glioblastoma/dt [Drug Therapy], glioblastoma/et [Etiology], mouse, nerve cell, nonhuman, overall survival, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/37600
Cancers
Click here for full text options
LibKey Link

مصطلحات الفهرس: protein cleavage, protein expression, protein function, protein interaction, protein localization, protein phosphorylation, survival rate, upregulation, dacomitinib/dt [Drug Therapy], epidermal growth factor receptor 4/ec [Endogenous Compound], messenger RNA/ec [Endogenous Compound], panitumumab, carcinogenicity, angiogenesis, animal cell, animal experiment, animal model, article, cancer prognosis, cancer survival, cell activation, cell count, cell growth, cell proliferation, concentration response, cross reaction, disease marker, drug efficacy, drug response, drug tolerability, glioblastoma/dt [Drug Therapy], glioblastoma/et [Etiology], mouse, nerve cell, nonhuman, overall survival, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/37600
Cancers
Click here for full text options
LibKey Link

مصطلحات الفهرس: nuclear magnetic resonance imaging, seizure/dt [Drug Therapy], vomiting, carboplatin/dt [Drug Therapy], clonazepam/dt [Drug Therapy], cyclophosphamide/dt [Drug Therapy], cyclophosphamide/iv [Intravenous Drug Administration], dexamethasone, etoposide/dt [Drug Therapy], filgrastim/sc [Subcutaneous Drug Administration], levetiracetam/dt [Drug Therapy], mesna, ondansetron, lip cyanosis, postoperative period, anisocoria, apnea, article, brain tumor, case report, clinical feature, craniotomy, cyanosis, cytoreductive surgery, female, glioblastoma/dt [Drug Therapy], histopathology, human, infant, neuroectoderm tumor/su [Surgery], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/39524
BMJ Case Reports
Click here for full text options
LibKey Link

مصطلحات الفهرس: priority journal, abscess/si [Side Effect], adult, aged, anemia/si [Side Effect], article, bleeding/si [Side Effect], cancer growth, clinical assessment, cognition, constipation/si [Side Effect], controlled study, death, deep vein thrombosis/si [Side Effect], diarrhea/si [Side Effect], drug efficacy, drug safety, drug withdrawal, fatigue/si [Side Effect], febrile neutropenia/si [Side Effect], female, glioblastoma/dt [Drug Therapy], human, hypertension/si [Side Effect], intention to treat analysis, major clinical study, male, nausea and vomiting/si [Side Effect], neutropenia/si [Side Effect], nuclear magnetic resonance imaging, overall survival, patient compliance, phase 2 clinical trial, progression free survival, prospective study, proteinuria/si [Side Effect], quality of life, randomized controlled trial, sensitivity analysis, thrombocytopenia/si [Side Effect], treatment response, alanine aminotransferase/ec [Endogenous Compound], bevacizumab/ae [Adverse Drug Reaction], bevacizumab/ct [Clinical Trial], bevacizumab/cb [Drug Combination], bevacizumab/dt [Drug Therapy], carboplatin/cb [Drug Combination], carboplatin/dt [Drug Therapy], etoposide/cb [Drug Combination], etoposide/dt [Drug Therapy], steroid, temozolomide/cb [Drug Combination], temozolomide/dt [Drug Therapy], Article

URL: Click here for full text options
LibKey Link